Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Perrigo Company (PRGO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 10,399,731
  • Shares Outstanding, K 138,460
  • Annual Sales, $ 4,946 M
  • Annual Income, $ 119,600 K
  • 36-Month Beta 0.77
  • Price/Sales 2.10
  • Price/Cash Flow 9.41
  • Price/Book 1.71

Price Performance

See More
Period Period Low Period High Performance
1-Month
71.37 +5.24%
on 05/14/18
80.53 -6.73%
on 04/25/18
-5.38 (-6.68%)
since 04/24/18
3-Month
71.37 +5.24%
on 05/14/18
89.50 -16.07%
on 02/26/18
-13.14 (-14.89%)
since 02/23/18
52-Week
63.68 +17.95%
on 08/09/17
95.93 -21.70%
on 01/26/18
+3.18 (+4.42%)
since 05/24/17

Most Recent Stories

More News
Today's Research Reports on Stocks to Watch: Precipio and Teva Pharmaceutical

NEW YORK, NY / ACCESSWIRE / May 15, 2018 / Shares of Precipio and Teva were gaining full speed on Monday. Precipio shares exploded after the company announced a substantial preliminary unaudited first...

PRPO : 0.55 (+7.84%)
PRGO : 75.11 (-0.07%)
Perrigo Confirms First To File Patent Challenge For Generic Version Of Ultravate® Lotion, 0.05%

Perrigo Company plc (NYSE; TASE: PRGO) today announced that Sun Pharmaceutical Industries, Inc. and MiCal Pharmaceuticals LLC initiated patent litigations on May 9 and 10, 2018, in the U.S. District Court...

PRGO : 75.11 (-0.07%)
Perrigo Expects Complete Response Letter On Generic Version Of ProAir®

Perrigo Company plc (NYSE; TASE: PRGO) today announced that it expects to receive a Complete Response Letter from the U.S. Food and Drug Administration (FDA) regarding its Abbreviated New Drug Application...

PRGO : 75.11 (-0.07%)
Perrigo (PRGO) Misses on Earnings in Q1, Reiterates View

Perrigo (PRGO) misses earnings estimates but exceeds revenue expectations in Q1. The company reiterates its revenue and adjusted earnings outlook for 2018.

PTGX : 6.61 (+2.96%)
LGND : 189.42 (-0.69%)
ILMN : 270.83 (-0.33%)
PRGO : 75.11 (-0.07%)
Medical Product Stocks May 8 Earnings List: HSIC, PEN & More

An important component of the broader Medical sector, the Medical Product space consistently grabs attention owing to a string of upsides.

HSIC : 70.51 (-0.16%)
PEN : 156.00 (-0.22%)
BIO : 289.06 (+0.05%)
HAE : 90.38 (-0.43%)
PRGO : 75.11 (-0.07%)
Perrigo Company plc Reports First Quarter 2018 Financial Results

-- Realized first quarter 2018 GAAP ("reported") net sales of $1.2 billion, reported net income of $81 million compared to $72 million last year, an increase of 12.9%, and reported diluted earnings per...

PRGO : 75.11 (-0.07%)
Is a Beat in the Cards for Perrigo (PRGO) in Q1 Earnings?

Perrigo's (PRGO) product purchases and introductions in the Rx segment might shoot up sales in the near future.

ADVM : 6.15 (unch)
AZN : 36.88 (+0.11%)
EBS : 50.61 (-0.90%)
PRGO : 75.11 (-0.07%)
Amneal And Impax Receive FTC Clearance For Business Combination

Amneal Pharmaceuticals LLC and Impax Laboratories, Inc. (NASDAQ: IPXL) today announced that the U.S. Federal Trade Commission (FTC) has cleared the Amneal and Impax business combination, subject to Amneal...

IPXL : 18.30 (unch)
ANIP : 62.94 (+0.78%)
PRGO : 75.11 (-0.07%)
Free Post Earnings Research Report: Perrigo Co.'s Quarterly Earnings Increased 3.23%

LONDON, UK / ACCESSWIRE / April 13, 2018 / Active-Investors.com has just released a free earnings report on Perrigo Co. PLC (NYSE: ). If you want access to this report all you need to do is sign up now...

PRGO : 75.11 (-0.07%)
Perrigo Launches Novel Omeprazole Orally Disintegrating Tablet to Treat Frequent Heartburn

Perrigo Company plc (NYSE; TASE: PRGO) and its partner Dexcel Pharma Technologies, Ltd., today announced the launch of store brand Omeprazole Delayed Release Orally Disintegrating Tablets 20mg (Omeprazole...

PRGO : 75.11 (-0.07%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators fully support a continuation of the trend.

See More Share

Trade PRGO with:

Business Summary

Perrigo Company plc develops, manufactures and distributes healthcare products. The company operates primarily in four segments: Consumer Healthcare, Nutritionals, Rx Pharmaceutical and Active Pharmaceutical Ingredients. It also provides animal health products. The company operates primarily in the United...

See More

Key Turning Points

2nd Resistance Point 76.22
1st Resistance Point 75.66
Last Price 75.11
1st Support Level 74.59
2nd Support Level 74.08

See More

52-Week High 95.93
Fibonacci 61.8% 83.61
Fibonacci 50% 79.81
Fibonacci 38.2% 76.00
Last Price 75.11
52-Week Low 63.68

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.

Free Barchart Webinar